Source: Program & Abstract Book. Conference titles: Annual Meeting of the North American Menopause Society. Unidade: FSP
Subjects: HORMÔNIOS, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO
ABNT
FALUDI, A. A. et al. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? 2000, Anais.. Orlando: The North American Menopause Society, 2000. . Acesso em: 03 set. 2024.APA
Faludi, A. A., Aldrighi, J. M., Bertolami, M. C., & Paes, M. S. (2000). Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? In Program & Abstract Book. Orlando: The North American Menopause Society.NLM
Faludi AA, Aldrighi JM, Bertolami MC, Paes MS. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? Program & Abstract Book. 2000 ;[citado 2024 set. 03 ]Vancouver
Faludi AA, Aldrighi JM, Bertolami MC, Paes MS. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? Program & Abstract Book. 2000 ;[citado 2024 set. 03 ]